The role of TST in the diagnosis of latent tuberculosis infection among military personnel in South Korea

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 12, 2006, Pages 1342-1346

  Choi, C M ^a   Kang, C I ^a   Kim, D H ^a   Kim, C H ^b   Kim, H J ^c   Lee, C H ^d   Yim, Jae Joon ^e  

^a The Armed Forces Capital Hospital   (South Korea)

^b Ministry of National Defense   (South Korea)

^c Korean Institute of Tuberculosis   (South Korea)

^d Korea Centers for Disease Control and Prevention   (South Korea)

^e Seoul National University College of Medicine   (South Korea)

Author keywords

Diagnosis; Latent tuberculosis; Military personnel; Tuberculin skin test

Indexed keywords

BCG VACCINE;

ADULT; ARTICLE; BCG VACCINATION; CLUSTER ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; INCIDENCE; INFECTION RISK; MYCOBACTERIUM TUBERCULOSIS; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; SCAR FORMATION; SOLDIER; SOUTH KOREA; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; BCG VACCINE; EARLY DIAGNOSIS; HUMANS; KOREA; MALE; MILITARY PERSONNEL; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; VACCINATION;

EID: 33845548162     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. World Health Organization. 2005 Global Report. Global tuberculosis control: surveillance, planning, financing. Geneva, Switzerland: WHO, 2005.
2. Jasmer R M, Nahid P, Hopewell P C. Clinical practice. Latent tuberculosis infection. N Engl J Med 2002; 347: 1860-1866.
3. American Thoracic Society (ATS). Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161 (Suppl): S221-S247.
4. Wang L, Turner M O, Elwood R K, et al. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 2002; 57: 804-809.
5. Scholten J N, Fujiwara PI, Frieden T R. Prevalence and factors associated with tuberculosis infection among new school entrants, New York City, 1991-1993. Int J Tuberc Lung Dis 1999; 3: 31-41.
6. Moreno S, Blazquez R, Novoa A, et al. The effect of BCG vaccination on tuberculin reactivity and the booster effect among hospital employees. Arch Intern Med 2001; 161: 1760-1765.
7. Tissot F, Zanetti G, Francioli P, et al. Influence of bacille Calmette-Guerin vaccination on size of tuberculin skin test reaction: to what size? Clin Infect Dis 2005; 40: 211-217.
8. Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005; 293: 2746-2755.
9. Kang Y A, Lee H W, Yoon H I, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005; 293: 2756-2761.
10. Comstock G W, Baum C, Snider D E Jr. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the Bethel isoniazid studies. Am Rev Respir Dis 1979; 119: 827-830.
11. Comstock G W, Ferebee S H, Hammes L M. A controlled trial of community-wide isoniazid prophylaxis in Alaska. Am Rev Respir Dis 1967; 95: 935-943.
12. Horwitz O, Payne P G, Wilbek E. Epidemiological basis of tuberculosis eradication. 4. The isoniazid trial in Greenland. Bull World Health Organ 1966; 35: 509-526.
13. Kang C I, Choi C M, Kim D H, et al. Pulmonary tuberculosis in young Korean soldiers: incidence, drug resistance and treatment outcomes. Int J Tuberc Lung Dis 2006; 10: 940-974.
14. Houk V N, Baker J H, Sorensen K, et al. The epidemiology of tuberculosis infection in a closed environment. Arch Environ Health 1968; 16: 26-35.
15. DiStasio A J, 2nd, Trump D H. The investigation of a tuberculosis outbreak in the closed environment of a U S Navy ship, 1987. Mil Med 1990; 155: 347-351.
16. LeMar J, Malakooti M, Sposato J, et al. Navy-Marine Corps team tuberculosis outbreak: 26th Marine Expeditionary Unit (Special Operations Capable), USS Wasp (LHD-1). Navy Medical Surveillance Report 1999; Apr-Jun: 6-11.
17. Whalen C C. Diagnosis of latent tuberculosis infection: measure for measure. JAMA 2005; 293: 2785-2787.
18. Ferebee S H. Controlled chemoprophylaxis trials in tuberculsis. A general review. Bibl Tuberc 1970; 26: 28-106.
19. Whalen C C, Johnson J L, Okwera A, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. N Engl J Med 1997; 337: 801-808.
20. Andersen P, Munk M E, Pollock J M, et al. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356: 1099-1104.
21. Soysal A, Millington K A, Bakir M, et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 2005; 366: 1443-1451.
22. Lockman S, Tappero J W, Kenyon T A, et al. Tuberculin reactivity in a pediatric population with high BCG vaccination coverage. Int J Tuberc Lung Dis 1999; 3: 23-30.
23. Fine P E, Ponnighaus J M, Maine N. The distribution and implications of BCG scars in northern Malawi. Bull World Health Organ 1989; 67: 35-42.
24. Hong Y P, Kim S J, Lew W J, Lee E K, Han Y C. The seventh nationwide tuberculosis prevalence survey in Korea, 1995. Int J Tuberc Lung Dis 1998; 2: 27-36.